Stem Cell Ophthalmology Treatment Study (SCOTS): Bone Marrow-Derived Stem Cells in the Treatment of Stargardt Disease
<b>Background:</b> Stargardt Disease is the most common inherited macular degeneration, typically resulting in progressive central vision loss and legal blindness at an early age. We report regarding 34 eyes with Stargardt Disease treated in the Stem Cell Ophthalmology Treatment Study (S...
Main Authors: | Jeffrey N. Weiss, Steven Levy |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Medicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2305-6320/8/2/10 |
Similar Items
-
Stem Cell Ophthalmology Treatment Study (SCOTS): Bone Marrow-Derived Stem Cells in the Treatment of Age-Related Macular Degeneration
by: Jeffrey N. Weiss, et al.
Published: (2020-03-01) -
Stem Cell Therapy in Stargardt Disease: A Systematic Review
by: Atousa Moghadam Fard, et al.
Published: (2023-07-01) -
Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow-derived stem cells in the treatment of Leber′s hereditary optic neuropathy
by: Jeffrey N Weiss, et al.
Published: (2016-01-01) -
Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a case report of improvement in relapsing auto-immune optic neuropathy
by: Jeffrey N Weiss, et al.
Published: (2015-01-01) -
Stem Cell Ophthalmology Treatment Study (SCOTS): improvement in serpiginous choroidopathy following autologous bone marrow derived stem cell treatment
by: Jeffrey N Weiss, et al.
Published: (2016-01-01)